NEW YORK (Reuters Health) – Prior research has linked the thiazolidinediones pioglitazone and rosiglitazone with an increased risk of heart failure, myocardial infarction, and death, but new research…
NEW YORK (Reuters Health) – A meta-analysis of trial data suggests that erythropoietin can be safely used to treat anemia in patients with chronic heart failure and may…
NEW YORK (Reuters Health) – Although spontaneous reperfusion during percutaneous angiography for treatment of ST-segment myocardial infarction (STEMI) occurs less often in patients with diabetes than in nondiabetics,…
NEW YORK (Reuters Health) – In a study of childhood cancer survivors, treatment with total body or abdominal irradiation was associated with an increased risk of diabetes later…
Charles Lockwood, MD, Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Services, Yale School of Medicine, discusses research initiatives looking at placental abruption and how it triggers…
NEW YORK (Reuters Health) – The well-known association between poor glycemic control and low HDL cholesterol in patients with type 2 diabetes is independent of obesity and hypertriglyceridemia,…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Residency Program Director, Director of Ophthalmic Plastics and Reconstructive Surgery Service, Yale University, discusses eye surgery transitioning from the…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Residency Program Director, Director of Ophthalmic Plastics and Reconstructive Surgery Service, Yale University, discusses thyroid eye disease, which is…
NEW YORK (Reuters Health) – Use of metformin is associated with a decreased risk of pancreatic cancer in patients with diabetes, new research shows. By contrast, treatment with…
NEW YORK (Reuters Health) – Even when patients with type 1 diabetes have excellent hemoglobin A1C levels, continuous glucose monitoring will be beneficial, according to a report in…